Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wave Life Sciences Ltd Files For Mixed Shelf Of Up To $500M

-Reuters

byBill Haddad

March 3, 2022

1 minute read

-Reuters

CytomX Therapeutics Announces Milestone Achievement In Probody T-Cell Engaging Bispecific Collaboration With Astellas

By Benzinga Newsdesk

Today, 6:31 AM

-Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to CytomX- -CytomX-retained US co-commercialization and economic rights

CTMX

Manhattan Associates Q2 EPS $0.69 Beats $0.53 Estimate, Sales $191.90M Beat $180.19M Estimate

By Benzinga Newsdesk

Today, 6:31 AM

Manhattan Associates (NASDAQ:MANH) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.53 by 30.19 percent. This is a 13.11 percent increase over earnings of $0.61 per share

MANH

Earnings Scheduled For May 18, 2022

By Benzinga Insights

Today, 6:31 AM

Companies Reporting Before The Bell • Sypris Solutions (NASDAQ:SYPR) is projected to report earnings for its first quarter.

ADI

News

HCW Biologics Enters CRADA With National Cancer Institute

By Benzinga Newsdesk

Today, 6:31 AM

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span

HCWB

Wave Life Sciences Ltd Files For Mixed Shelf Of Up To $500M

Related Posts

CytomX Therapeutics Announces Milestone Achievement In Probody T-Cell Engaging Bispecific Collaboration With Astellas

Manhattan Associates Q2 EPS $0.69 Beats $0.53 Estimate, Sales $191.90M Beat $180.19M Estimate

Earnings Scheduled For May 18, 2022

HCW Biologics Enters CRADA With National Cancer Institute